Sorli C, Harashima SI, Tsoukas GM et al (2017) Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Ongoing monitoring helps adjust dosing and address plateaus while preserving lean mass and metabolic health
Always check your Mounjaro pen to ensure its not frozen before use
This depends on your plan's drug list
A thinner person could use a needle that's an inch long
When a drug is on the shortages list, compounders may be able to make their own version of that drug, if they meet certain federal requirements